Background: In this study the effects of treatment with cognitive therapy, antidepressants or pill-placebo on the locus of control orientation in panic disorder patients were analysed, as well as the relation of this panic locus of control with panic frequency and cognitive measures of panic. Methods: A Multidimensional Anxiety Locus of Control scale (MALC) was developed and completed with other measures (ACQ and BSQ) before and after treatment. Patients also kept a panic diary. Results: Four subscales were derived from the MALC: one Internal, and three external (a Chance, a Medication, and a Therapist) locus of anxiety control orientation scales. Cognitive therapy was superior over pill-placebo on most outcome measures whereas antidepressants were only superior in reducing the number of panic attacks. Treatment with cognitive therapy resulted in an increase of ‘internal’ anxiety control orientation and a decrease of ‘chance’ and ‘medication’ orientation, in comparison with antidepressant therapy. The residualized gain scores on the MALC subscales correlated with clinical improvement in subjects treated with cognitive therapy only. Conclusions: Results suggest that the locus of control orientation is important in evaluating the differential effects of treatments in panic disorder. A differential effect on panic locus of control in favor of cognitive therapy in comparison to medication was found.

Keywords:
Panic disorder, Agoraphobia, Treatment, Psychotherapy, Cognitive therapy, Medication, Antidepressant, Locus of control
1.
Clark DM: A cognitive approach to panic. Behav Res Ther 1986;24:461–470.
2.
Lazarus RS, Folkman S: Stress, Appraisal and Coping. New York, Springer, 1984.
3.
Chambless DL, Caputo GC, Bright P, Gallagher R: Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. J Consult Clin Psychol 1984;52:1090–1097.
4.
Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder MG: A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164:759–769.
5.
Rotter JB, Seeman M, Liverant S: Internal versus external control of reinforcements: A major variable in behavior theory. Decisions Values Groups 1962;2:473–516.
6.
Wallston BS, Wallston KA, Kaplan GD, Maides SA: Development of the Multidimensional Health Locus of Control (MHLC) Scales. Hlth Educ Monogr 1978;6:160–169.
7.
ter Kuile MM, Spinhoven P, Linssen ACG, van Houwelingen HC: Cognitive coping and appraisal processes in the treatment of chronic headaches. Pain 1996;64:257–264.
8.
van Peski-Oosterbaan AS, Spinhoven P, van der Does AJW, Bruschke AVG, Rooijmans HGM: Cognitive change following cognitive behavioural therapy for non-cardiac chest pain. Psychother Psychosom 1999;68:214–220.
9.
Bakker A, van Dyck R, Spinhoven P, van Balkom AJLM: Paroxetine, clomipramine and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry 1999;60:831–838.
10.
Bakker A, Spinhoven P, van Baldom AJLM, Vleugel L, van Dyck R: Cognitive therapy by allocation versus cognitive therapy by preference in the treatment of panic disorder. Psychother Psychosom 2000;69:240–243.
11.
Cloitre M, Heimberg RG, Liebowitz MR, Gitow A: Perceptions of control in panic disorder and social phobia. Cogn Ther Res 1992;16:569–577.
12.
Basoglu M, Marks IM, Kilic C, Brewin CR, Swinson RP: Alprazolam and exposure for panic disorder with agoraphobia: Attribution of improvement to medication predicts subsequent relapse. Br J Psychiatry 1994;164:652–659.
13.
Ryff CD, Singer BH: Biopsychosocial challenges of the new millenium. Psychother Psychosom 2000;69:170–177.
14.
Schnyder U, Buchi S, Sensky T, Klaghofer R: Antonovsky’s sense of coherence. Psychother Psychosom 2000;69:296–302.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.